Deep Vein Thrombosis (DVT)

Slides:



Advertisements
Similar presentations
Farmaci usati prima dellintervento Basi farmacologiche del loro uso La prevenzione del tromboembolismo.
Advertisements

Hollie Shaner-McRae DNP RN FAAN
Deep Vein Thrombosis (DVT) Know the Signs. Listen to Your Body
VTE Prophylaxis in the Hospitalized Patient: Importance and Strategies for Improved Compliance Andrew H. Dombro, M.D. Instructor of Medicine Division of.
Preventing VTE in Surgical Patients. Today’s Topics The common sense science of VTE prevention Brief history of VTE prevention techniques High yield methods.
Newer Anticoagulants Drug Class Nicole N. Nguyen, PharmD Senior Clinical Pharmacist Health Care Services October 16, 2013.
DVT Prophylaxis Suzie Feuling ProHealth Care Waukesha, Wisconsin.
Venous Thromboembolism Prevention August Venous Thromboembloism Prevention 2 Expected Practice  Assess all patients upon admission to the ICU for.
Venous Thromboembolism Prophylaxis and Management in the Medical Patient at Sisters of Charity Hospital Jeffrey Parker, DO Dr. Nashat Rabadi, MD Sisters.
Prophylaxis of Venous Thromboembolism
Venous thromboembolism –
Venous Thromboembolism (VTE) Prophylaxis Policy Mary-Anne Davies Patient Safety Specialist Accreditation Coordinator.
Venous Thromboembolism
Perioperative Medicine Beyond Cardiac Clearance Pamela Pride MD July 31, 2012 MUSC.
RecommendationsRecommendations Risk Recommendation Ambulation (all pts) IPC/GCS or, UFH 5000 SQ q 12 hrs or, Enoxaparin 40mg SQ daily IPC/GCS or, UFH 5000.
QAH HospitalPortsmouth Hospitals NHS Trust Venous Thromboembolism Patient Safety Study Day Simon Freathy.
VTE Prophylaxis Alert to providers and nursing Go live June 24, 2014.
CMS Core Measures Evidence-Based Performance Measurement.
Venous ThromboEmbolism
CHEST-2012: High Points and Pearls Alan Brush, MD, FACP Chief, Anticoagulation Management Service Harvard Vanguard Medical Associates.
DPT 732 SPRING 2009 S. SCHERER Deep Vein Thrombosis.
Ferris State University Nursing Research Presented by: Rebecca Enright, Jiali Luc, Jenny Parish, Ashley Weststrate.
DVT/VTE Nursing Protocol (Deep Vein Thrombosis) (Venous Thromboembolism) Presented by Maribeth Desiongco MA, RN-BC 2008.
+ Pulmonary Embolus By: Marissa Miuccio. + What is a Pulmonary Embolism Pulmonary Embolism, or PE, is a sudden blockage in a lung artery. The blockage.
Chapter Three Venous Disease Coalition Epidemiology of VTE Risks, Risk Factors VTE Toolkit.
2007 Deep Vein Thrombosis (DVT) Awareness Program
Medical Patients – VTE Prevention Dale W. Bratzler, DO, MPH Professor and Associate Dean, College of Public Health Professor of Medicine, College of Medicine.
Cost-Conscious Care Presentation Follow-up Chest X-Ray in Patients Admitted for Community Acquired Pneumonia Huy Tran, PGY-2 12/12/2013.
Thromboembolism IT training Presentation Midwifery update Marie Lewis.
What You Need to Know about Blood Clots. What You Need to Know About Blood Clots or Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE)
Stroke Quality Measures Kathy Wonderly RN, BSPA, CPHQ Performance Improvement Coordinator Developed: May, 2012 Most recently updated: October,
PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM
Postoperative venous thromboembolic disease prevention in the neurosurgery population Ahmad Khaldi, M.D. 1 Michael Wall, PharmD 2 T.C. Origitano, M.D.,
Thromboprophylaxis in Pregnancy and the Puerperium
1 VTE Protocol Presented by: Selina Baskins, RN Quality Coordinator.
Risk assessment for VTE
Prevention of Venous Thromboembolism 8 th ACCP Guidelines Chest 2008.
Surgical Care Improvement Project Prevention of Post-operative Venous Thromboembolism Team Membership Department of Surgery, Nursing, General Medicine,
VTE Venous ThromboEmbolism. VTE – aims of this module To define the terms associated with VTE and offer maximum care to treat patients. To define the.
LIFEBLOOD THE Thrombosis CHARITY LIFEBLOOD THE Thrombosis CHARITY NICE Clinical Guideline 46.
Venous Thromboembolism Prophylaxis for Medical Inpatients Heather Hofmann, rev. 4/18/14 DSR2 Mini Lecture.
Cost-Consciousness Assignment Ollie Ross DSR 2. Adherence to ACP DVT prophylaxis guidelines Objective: Evaluate adherence to ACP DVT prophylaxis guidelines.
DVT & PE: How early can I mobilize a patient ??
Risk Assessment for VTE. Which of the following best describes you?
Prophylaxis Diagnosis Treatment Venous Thromboembolism Management.
Surgical Care Improvement Project Prevention of Post-operative Venous Thromboembolism Team Membership Department of Surgery, Nursing, Pharmacy, CCE Confidential:
Confidential: Quality Improvement Material Reducing Clotting Events for Post-Surgical Orthopedic Patients Loyola Anticoagulation Clinic Spring 2009.
 Deep Vein Thrombosis Josh Vrona, Hunter Dolan, Erin McCann.
Deep vein thrombosis and pulmonary embolism.
DEEP VEIN THROMBOSIS (DVT) BY CJ HEYKOOP AND KAYTLYN JORDAN.
DVT cases.  Heparin, low molecular weight heparin, or fondaparinux are usually continued for at least five days, along with another medication called.
Venous Thromboembolism (VTE) Prophylaxis at Cesarean Section Phillip N. Rauk, MD.
Venous Thromboembolism (VTE) Etiology, Prevention, Recognition, and Treatment 1.
Antithrombotic Therapy for VTE: CHEST Guidelines 2016
Venous Thromboembolic (VTE) Prophylaxis in Pediatric Trauma Patients Bowe.
Cardiovascular Disease (CVD) Objectives: Describe the movement of blood through the cardiovascular system Discuss the prevalence of CVD Define the types.
Dr Thomas Lloyd F1 Dr Aman Hargehandewal Wrexham Maelor Hospital
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke Antithrombotic Therapy and Prevention of Thrombosis: ACCP Evidence-Based Clinical Practice.
One of the main causes of DVT is inactivity! When a person is inactive, your blood normally collects in the lower part of your body. (in your legs) This.
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke Antithrombotic Therapy and Prevention of Thrombosis: ACCP Evidence-Based Clinical Practice.
Dr. Lesbia Adalgisa Rodriguez PGY3-Cook County Loyola Family Medicine Residency Program Venous Thromboembolism Prophylaxis in the Inpatient Setting.
What Is Deep Vein Thrombosis (DVT)? DVT is a blood clot that forms in a vein deep in the body Most often occurs in the deep veins of the legs, either.
Venous Thromboembolism Prophylaxis for Medical Inpatients
Clinical Knowledge Summaries CKS Pulmonary embolism (PE)
UNDERSTANDING YOUR RISK FOR DEVELOPING BLOOD CLOTS (VTE) IN CANCER
Dr.H.Chandrashekar, Dr.A.Chaudhuri, Dr. A. Douglas, Dr. D. Lowdon
UNDERSTANDING YOUR RISK FOR DEVELOPING BLOOD CLOTS (VTE) IN CANCER
Pulmonary Thrombo-Embolism
Presentation transcript:

Deep Vein Thrombosis (DVT) Education for Nurses

Objectives Identify risk factors for the development of Deep Vein Thrombosis (DVT) Describe the nurse’s role in DVT prevention Discuss the process for DVT prophylaxis at LVH

Did You Know? Up to 2 million people in the United States suffer from DVT every year. Approximately 600,000 experience pulmonary embolism (PE). Venous Thromboembolism (VTE) is the term commonly used to describe both DVT and PE. 1 1 Hirsh, Hoak. Circulation. 1996;93:2212-2245.

Did You Know? For up to 200,000 of those with PE, the blood clot in the lung proves fatal – killing more people than AIDS and breast cancer combined. 2-6 Bick. Drugs. 2000;60:575-595. Kim, Spandorfer. Emerg Med Clin North Am. 2001;19:839-859. Anderson et al. Arch Intern Med. 1991;151:933-938. Centers for Disease Control. Available at: http://www.cdc.gov. American Cancer Society. Available at: http://www.cancer.org.

Oh, I just saw Mrs. Smith in the ER last week with the flu Oh, I just saw Mrs. Smith in the ER last week with the flu. I wonder why she was admitted with DVT!!

Risk Factors for DVT Medical conditions, such as: Coronary Artery Disease Heart Failure Exacerbation of COPD or other severe respiratory disease Acute MI Trauma/Burns Sepsis Inflammatory bowel disease Lupus Stroke

Risk Factors for DVT 7,8 Illness or injury that causes prolonged immobility Age > 40 Pregnancy, birth control pills and hormone replacement therapy Cancer and its treatment Major surgery (ex: abdomen, pelvis, hip facture, knee fracture, hip or knee replacement) Surgery time > 30 minutes Obesity Indwelling vascular devices Previous DVT or PE Geerts et al. Chest. 2001;119(suppl):132S-175S. National Experts’ Consensus Panel for Clinical Excellence in Thrombosis Management. Available at: http://www.thrombosis-consult.com.

I wonder if Mrs. Smith was at risk for DVT?

Was Mrs. Smith at Risk for DVT? 47 years old She is recuperating from surgery (abdominal hysterectomy) one month ago. She was just in the emergency dept. with flu-like symptoms; has spent the last 3 days in bed. She has a history of Lupus. Yes! She certainly had several risk factors. The more risk factors a patient has, the greater the risk for DVT.

Could Mrs. Smith’s DVT have been prevented? Evidenced based CHEST Guidelines recommend: Identifying hospitalized patients that are at high risk for developing DVT Implementing interventions to prevent DVT

Let’s review the important interventions for the prevention of DVT: Ambulation early and often (simplest and most cost effective means to reduce risk of DVT) Intermittent External Compression Devices: Also called sequential compression devices or SCDs They increase rate/velocity of venous blood and reduce pooling in the peripheral veins Compression should begin pre-operatively and be continued until the patient is fully ambulatory Anticoagulant Medication Therapy

Medication for DVT Prevention Chest Guidelines recommend Enoxaparin for the prevention of DVT.

Medication for DVT Prevention Enoxaparin: Also known by the trade name Lovenox Always administered subcutaneously Usual dose is 40mg per day for medically ill patients If Creatinine Clearance is <30ml/min, adjusted dose is 30mg per day

Medication for DVT Prevention Enoxaparin: Also known by the trade name Lovenox Always administered subcutaneously Usual dose is 40mg per day for medically ill patients If Creatinine Clearance is <30ml/min, adjusted dose is 30mg per day

What’s happening at Lehigh Valley Hospital? We are focusing on DVT prophylaxis for all in-patient admissions. The following screen will be attached to all admission order screens in Last Word. Requires the physician to place the order for the appropriate DVT prophylaxis

Physician Order

Physician Order (continued) If DVT prophylaxis is NOT indicated…. the reason must be identified.

Physician Order (continued) Reasons why prophylaxis may not be indicated include: Patient is fully ambulatory and is expected to be hospitalized for less than 24 hours The patient declines DVT prophylaxis The patient is fully anticoagulated

Physician Order (continued) The following screens show: How the order will appear on the patient’s active order list The detail screen for the order

Physician Order (continued)

Physician Order (continued)

Diagnosing DVT Clinical diagnosis of DVT is unreliable because classic symptoms (pain, swelling, tenderness, and warmth) may not be present. Therefore it is important for ALL healthcare professionals to collaborate in the identification of high risk patients and implement prophylaxis.

Patient Education It is important that our patients are included in the plan for prevention of DVT.

Patient Education Education material available to our patients includes: Patient education video “DVT Prevention” available on CCTV Written material: Learn More About Deep Vein Thrombosis Learn More About Pulmonary Emboli

Remember Major risk factors for DVT include: heart failure, severe respiratory disease and sepsis. All patients’ DVT risk factors are identified on admission. If an acutely ill hospitalized patient has a major risk factor for DVT or is confined to bed and has one or more additional risk factors, then prophylaxis is recommended.

Contact your unit Patient Care Specialist (PCS) Congratulations You have completed the DVT learning module. If you need more information: Contact your unit Patient Care Specialist (PCS)